AME vs TECH · P/E 30, rev $6.94B vs P/E 65, rev $1.22B
Ametek Inc (AME) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported AME revenue for 2024-12-31 was $6.94B. Net income was $1.38B. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
AME currently screens at market cap $42.11B and trailing P/E 29.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the AME and TECH stock pages for the full models.
Not investment advice.